Schedule 13G ownership disclosure

IntelliPharmaCeutics International Inc.

Security class unavailable · CUSIP: 458173101

Event date: 2018-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-189507
Form type
SC 13G
Filer
Intellipharmaceutics International Inc.
CIK
CIK 1474835
Filed
Jun 11, 2018
Reporting period
May 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub